Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

SEL Manufacturing Company Limited

Clarification - Financial Results

The NSE has requested clarification from SEL Manufacturing Company Limited regarding its financial results for the quarter ended March 31, 2026. This query pertains to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which typically deals with the submission and review of financial statements. The Exchange is awaiting the company's official response to this clarification request, indicating potential discrepancies or non-compliance in the reported financials.

NSEClarification - Financial Results▼ NegativeRegulatory24 Jun 2026

Unitech Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has sought clarification from Unitech Limited regarding its financial results for the quarter ended March 31, 2026, citing Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to this regulatory query is currently awaited, indicating a potential issue with financial reporting or compliance.

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Enviro Infra Engineers Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has requested clarification from Enviro Infra Engineers Limited regarding its financial results for the quarter ended March 31, 2026. This clarification was sought under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's official response to this regulatory query is currently pending.

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Atcom Technologies Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has requested clarification from Atcom Technologies Limited concerning its financial results for the quarter ended March 31, 2026. This request was made under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating potential discrepancies or missing information in the company's financial disclosures. The company's official response to the exchange's query is currently awaited, creating uncertainty regarding the accuracy and completeness of its reported earnings.

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Madhucon Projects Limited

Clarification - Financial Results

The National Stock Exchange has requested clarification from Madhucon Projects Limited concerning its financial results for the quarter ended March 31, 2026, under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific nature of the query is not disclosed in this announcement. The company's official response to the exchange's clarification request is currently pending.

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Sadbhav Infrastructure Project Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has sought clarification from Sadbhav Infrastructure Project Limited concerning its financial results for the quarter ended March 31, 2026. This request was made under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to financial reporting. The company's official response to the clarification sought by the Exchange is currently awaited.

NSEPress Release▲ PositiveExpansion24 Jun 2026

Shilpa Medicare Limited

Press Release

Shilpa Medicare Limited, through its material subsidiary Shilpa Biologicals Private Ltd, has commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility. This facility is one of India's few integrated sites for ADC Drug Substance production, designed to meet global regulatory standards. Leveraging Shilpa's 25-year expertise in highly potent compounds, this expansion strategically positions the company as a key Contract Development and Manufacturing Organization (CDMO) partner for global biotech and pharmaceutical companies in the high-value oncology segment.

Read more →📎 1 attachment
NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Mahalaxmi Fabric Mills Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has sought clarification from Mahalaxmi Fabric Mills Limited regarding its financial results for the quarter ended March 31, 2026. This query pertains to compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to the exchange's request for clarification is currently awaited.

NSEClarification - Financial Results▼ NegativeResults24 Jun 2026

Om Freight Forwarders Limited

Clarification - Financial Results

The National Stock Exchange (NSE) has requested clarification from Om Freight Forwarders Limited concerning its financial results for the quarter ended March 31, 2026. This clarification is sought under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's official response to the exchange's query is currently awaited.

NSEClarification - Financial ResultsResults24 Jun 2026

Best Agrolife Limited

Clarification - Financial Results

The NSE has sought clarification from Best Agrolife Limited regarding its financial results for the quarter ended March 31, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to the exchange's request is currently awaited. This indicates a potential discrepancy or query related to the reported financial data, introducing uncertainty for investors.

NSEPress Release▲ PositiveOrder Win24 Jun 2026

Biocon Limited

Press Release

Biocon Limited announced that its partner, Duopharma Biotech, secured multiple insulin tenders from Malaysia's Ministry of Health, valued at over MYR 225 million. Biocon's Malaysian subsidiary will supply short-acting recombinant human insulin, insulin glargine, and insulin aspart under these contracts, which include a three-year human insulin agreement and two-year agreements for insulin glargine and aspart. This reinforces Biocon's commitment to diabetes care in Malaysia, ensuring continued access to high-quality, cost-effective insulin therapies and strengthening its market presence.

Read more →📎 1 attachment
NSECredit Rating- Revision▲ PositiveRating Change24 Jun 2026

Aye Finance Limited

Credit Rating- Revision

Aye Finance Limited has received an upgrade in its credit ratings from India Ratings and Research (Ind-Ra). The long-term debt instruments and issuer rating were upgraded to 'IND A+/Stable' from 'IND A/Stable', while commercial papers were upgraded to 'IND A1+' from 'IND A1'. This upgrade reflects improved capitalisation from a recent IPO, a strengthened secured loan mix, enhanced profitability buffers, and a more diversified funding profile. The ratings also acknowledge the company's focus on expanding its mortgage product portfolio.

Read more →📎 1 attachment
NSEGeneral Updates24 Jun 2026

Max Estates Limited

General Updates

Max Estates Limited announced the allotment of 9,644 equity shares, each with a face value of INR 10/-, to option holders under its Employee Stock Option Plan 2023. This routine corporate action, approved by the Nomination and Remuneration Committee on June 23, 2026, resulted in a minor increase in the company's paid-up equity share capital from INR 1,63,48,76,260 to INR 1,63,49,72,700.

Read more →📎 1 attachment
NSEGeneral Updates24 Jun 2026

Tech Mahindra Limited

General Updates

Tech Mahindra Limited has informed shareholders about the dispatch of its Integrated Annual Report for FY 2025-26 and the Notice for its 39th Annual General Meeting (AGM), scheduled for July 17, 2026, via virtual conferencing. The company has provided exact weblinks, paths, and QR codes for accessing these documents for shareholders whose email addresses are not registered. Additionally, the announcement highlights the "Saksham Niveshak - 100 days Campaign" for unclaimed dividends and a special window for dematerialization of physical shares. This is a standard compliance filing under SEBI Listing Regulations.

Read more →📎 1 attachment
NSEGeneral UpdatesESG24 Jun 2026

Tech Mahindra Limited

General Updates

Tech Mahindra Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, along with an External Assurance Report on BRSR Core. This submission is made in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The BRSR provides detailed disclosures on the company's ESG performance, operational activities, and sustainability initiatives for the reported fiscal year.

Read more →📎 1 attachment
NSEShareholders meeting▲ PositiveDividend23 Jun 2026

Tech Mahindra Limited

Shareholders meeting

Tech Mahindra Limited announced its 39th Annual General Meeting (AGM) to be held on July 17, 2026, through Video Conferencing. The key agenda items include the adoption of audited financial statements for FY2025-26 and the re-appointment of Dr. Anish Shah as a Non-Executive Director. Importantly, the company proposes to confirm an interim dividend of ₹15/- per equity share and declare a final dividend of ₹36/- per equity share for the financial year 2025-26, resulting in a total dividend of ₹51/- per share for the year.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveExpansion23 Jun 2026

SIGMA ADVANCED SYSTEMS LIMITED

General Updates

SIGMA ADVANCED SYSTEMS LIMITED released its Corporate Presentation for June 2026, outlining its transformation into a Tier 1 Global Aerospace & Defense player. The presentation showcases a diversified portfolio including drones, missile systems, avionics, aero-engines, and airframes, backed by strong R&D, a 90%+ international order book up to 8 years, and a dual manufacturing footprint in UK and India. It highlights strategic acquisitions like Nasmyth and Export Bridge to enhance capabilities and global market access, emphasizing the company's integrated value chain play and strategic partnerships for future growth.

Read more →📎 1 attachment
NSEUpdates▲ PositiveFundraise23 Jun 2026

Balrampur Chini Mills Limited

Updates

Balrampur Chini Mills Limited has received listing approval from the National Stock Exchange of India Limited and BSE Limited for 9,316,771 equity shares. These shares, with a face value of Re. 1/- each, were issued at a price of Rs. 483/- per share (including a premium) to promoters and non-promoters on a preferential basis. This approval formalizes the successful completion of the preferential allotment, allowing the newly issued shares to be admitted for trading on the exchanges.

Read more →📎 1 attachment
NSEGeneral Updates23 Jun 2026

Reliance Infrastructure Limited

General Updates

Reliance Infrastructure Limited has published a newspaper notice announcing a special window for the transfer and dematerialisation of physical shares. This initiative, mandated by a SEBI Circular, is open until February 04, 2027, and facilitates the dematerialisation of shares sold or purchased before April 01, 2019. This is a compliance-driven update aimed at assisting shareholders.

Read more →📎 1 attachment
NSEPrice movement23 Jun 2026

Standard Engineering Technology Limited

Price movement

Standard Engineering Technology Limited responded to a National Stock Exchange (NSE) inquiry regarding significant share price movement. The company clarified that it has been complying with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has timely disclosed all material information. It stated that there is no undisclosed information or impending announcement that could explain the price or volume fluctuations. The company attributes the share price movement solely to market-driven factors, asserting no control or knowledge of specific reasons.

Read more →📎 1 attachment
Page 1 of 105Next →